Pexiganan vs Phylloseptin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Pexiganan (MSI-78) is a synthetic analog of magainin-2, optimized for enhanced broad-spectrum antimicrobial activity and reduced hemolytic toxicity. It was developed by Magainin Pharmaceuticals (later Genaera) as a topical treatment for mildly infected diabetic foot ulcers....
Calculate Pexiganan dose →Phylloseptins are a family of short, C-terminally amidated alpha-helical antimicrobial peptides isolated from the skin secretions of South American Phyllomedusa frogs. Unlike the related dermaseptins from the same genus, phylloseptins are shorter (19 residues) and show a distinct...
Calculate Phylloseptin dose →| Parameter | Pexiganan | Phylloseptin |
|---|---|---|
| Category | Antimicrobial Peptide | Antimicrobial Peptide |
| Research | Phase 3 (Failed 1999) | Preclinical |
| Half-Life | Hours (topical) | Minutes (proteolytic) |
| Typical Dose | 0.8% cream topically | N/A |
| Frequency | Twice daily | N/A |
| Route | Topical cream | Research only |
| FDA Status | Not approved (failed Phase 3) | Not approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.